KUALA LUMPUR, Jan 24 -- Meridian Bioscience Inc has launched a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification, but also offers market-leading amplification for companion diagnostic and clinical testing.
High-fidelity amplification is essential for applications whose outcome depends upon the correct DNA sequence, such as next generation sequencing (NGS), cloning and genotyping.
However, results from such amplifications can be compromised by a DNA polymerase incapable of evenly amplifying diverse types of sequences or if samples contain inhibitors.
The Life Science Division of Meridian Bioscience has addressed these challenges by developing High-Specificity Pfu HS Mix as a high-fidelity amplification solution, with market leading properties in terms of inhibitor resistance, multiplexing and low GC bias.
It is a perfect tool for NGS technologies applied to the clinical market, especially in the field of genetic testing and cancer screening, i.e., the development of panels for tumour or mutation profiling.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. More details at www.meridianbioscience.com
-- BERNAMA
No comments:
Post a Comment